As of January 2025, efgartigimod is the only FcRn antagonist with registered (albeit in not all cases ongoing) trials within bullous pemphigoid, post-coronavirus disease 2019 (COVID-19) postural orthostatic tachycardia syndrome, membranous nephropathy, and antineutrophil cytoplasmic antibody-associated vasculitis, and disclosed development plans detail an investigation of efgartigimod within more than ten indications [245]
This decision made it so I could walk and start doing something that has been a part of my life for almost 15 years
In this blog, were taking a deep dive into Leaky Gut Syndrome, and how our microbiome can both cause and prevent it
Some patients explore peptide therapy as part of broader wellness and body composition goals that may include exercise, nutrition, and healthy lifestyle modifications
Skin manifestations of suspected COVID-19: complications of the disease or reactivation of latent viral infections
Sun Valley Ski Resort in Idaho is a bucket-list destination for adventure seekers and outdoor lovers alike